OptimizeRx (OPRX) Revenue (2010 - 2026)

OptimizeRx has disclosed Revenue across 17 years of filings, most recently posting $20.5 million for Q2 2026.

• In Q2 2026, Revenue fell 29.77% year-over-year to $20.5 million; the TTM figure through Jun 2026 stood at $98.7 million (down 5.82% YoY), while the FY2025 annual figure was $109.4 million, up 18.78% from the prior year.
• Revenue came in at $20.5 million for Q2 2026 at OptimizeRx, up from $19.8 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $32.3 million in Q4 2024 to a low of $13.0 million in Q1 2023.
• Average Revenue over 5 years is $20.9 million, with a median of $19.8 million recorded in 2024.
• Year-over-year, Revenue soared 55.19% in 2025 and retreated 29.77% in 2026.
• Over 5 years, Revenue stood at $19.7 million in 2022, then surged by 44.34% to $28.4 million in 2023, then gained by 13.91% to $32.3 million in 2024, then fell by 0.24% to $32.2 million in 2025, then tumbled by 36.4% to $20.5 million in 2026.
• Per Business Quant data, the three most recent Revenue figures were $20.5 million in Q2 2026, $19.8 million in Q1 2026, and $32.2 million in Q4 2025.